Polypill for cardiovascular disease prevention.

Polypill for cardiovascular disease prevention.

Библиографические подробности
Главный автор:	Dalton, A
Формат:	Journal article
Язык:	English
Опубликовано:	2013

Схожие документы

Polypills with or without aspirin for primary prevention of cardiovascular disease
по: Mant, J, и др.
Опубликовано: (2021)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
по: Apichard Sukonthasarn, и др.
Опубликовано: (2021-03-01)

Medicinal herbs: Potential polypills in cardiovascular diseases
по: Samaneh Noroozi, и др.
Опубликовано: (2021-04-01)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
по: Omneya A. Kandil, и др.
Опубликовано: (2022-04-01)

The polypill: the solution for prevention of coronary heart disease?
по: Hendarto Natadidjaja
Опубликовано: (2016-02-01)

THE ROLE OF POLYTABLETS (POLYPILL) IN THE TREATMENT OF CHRONIC CARDIOVASCULAR DISEASES
по: Николай Владимирович Абрамов, и др.
Опубликовано: (2024-02-01)

Polypill versus medication monotherapy in the prevention of cardiovascular diseases in Iran: An economic evaluation study
по: Ramin Ravangard, и др.
Опубликовано: (2024-07-01)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
по: Lilian Grigorian-Shamagian, и др.
Опубликовано: (2021-08-01)

The use of polypills in cardiovascular disease management: Benefits vs challenges
по: Yamaan Adil, и др.
Опубликовано: (2024-09-01)

Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review
по: Lopez-Lopez JP, и др.
Опубликовано: (2023-09-01)

A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
по: Gautam Satheesh, и др.
Опубликовано: (2024-07-01)

Redefining the polypill: pros and cons in cardiovascular precision medicine
по: Siddharth Birla, и др.
Опубликовано: (2023-09-01)

Exercise Rehabilitation in Heart Disease: the real “polypill” for primary and secondary prevention
по: Massimo F. Piepoli
Опубликовано: (2005-06-01)

Correction: A Survey of Availability and Affordability of Polypills for Cardiovascular Disease in Selected Countries
по: Gautam Satheesh, и др.
Опубликовано: (2024-08-01)

Preventing the progression of climate change: one drug or polypill?
по: Hugh Montgomery
Опубликовано: (2017-03-01)

Polypill holds promise for people with chronic disease
по: Jacqui Wise
Опубликовано: (2005-12-01)

Polypill" conception in modern cardiology
по: I E Chazova, и др.
Опубликовано: (2018-12-01)

Cost-Effectiveness of the CNIC-Polypill Strategy Compared With Separate Monocomponents in Secondary Prevention of Cardiovascular and Cerebrovascular Disease in Portugal: The MERCURY Study
по: Carlos Aguiar, и др.
Опубликовано: (2022-11-01)

Cost-effectiveness of fixed-dose combination pill (Polypill) in primary and secondary prevention of cardiovascular disease: A systematic literature review.
по: Reza Jahangiri, и др.
Опубликовано: (2022-01-01)

Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study
по: Cordero A, и др.
Опубликовано: (2023-07-01)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease
по: Jowett, S, и др.
Опубликовано: (2017)

Three-dimensional printing of flexible polypill
по: Yasir Karkar, и др.
Опубликовано: (2023-12-01)

Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease.
по: Sue Jowett, и др.
Опубликовано: (2017-01-01)

Polypill Brings Benefits to Patients with Cardiovascular Disease, Both Improving Medication Adherence and Demonstrating the Concept of Chronotherapy [Letter]
по: Zhu LL, и др.
Опубликовано: (2023-09-01)

The Benefits of Polypill: Adherence and Chronotherapy [Response to Letter]
по: Lopez-Jaramillo P, и др.
Опубликовано: (2023-10-01)

Has the polypill finally proven its worth?
по: Treadwell, J
Опубликовано: (2019)

Inclusion of Polypills for Prevention of Cardiovascular Disease in the 23rd World Health Organization Model List of Essential Medicines: A Significant Step Towards Reducing Global Cardiovascular Morbidity and Mortality
по: Anubha Agarwal, и др.
Опубликовано: (2024-02-01)

The cardiovascular polypill as baseline treatment improves lipid profile and blood pressure regardless of body mass index in patients with cardiovascular disease. The Bacus study.
по: José Alejandro Chávez Fernández, и др.
Опубликовано: (2023-01-01)

Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk
по: Usherwood Tim, и др.
Опубликовано: (2010-08-01)

Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study
по: Virdee, S, и др.
Опубликовано: (2013)

Effect of a Cardiovascular Polypill on Poststroke Cognition Among Ghanaians: Secondary Analysis of a Randomized Clinical Trial
по: Fred Stephen Sarfo, и др.
Опубликовано: (2024-08-01)

Randomized Polypill crossover trial in people aged 50 and over.
по: David S Wald, и др.
Опубликовано: (2012-01-01)

Polypill therapy and frailty in elderly: Time to stop treating everything
по: Sunil Kumar, и др.
Опубликовано: (2021-04-01)

The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials.
по: C Raina Elley, и др.
Опубликовано: (2012-01-01)

Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia
по: Hae Won Jung, и др.
Опубликовано: (2023-09-01)

An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.
по: PILL Collaborative Group, и др.
Опубликовано: (2011-01-01)

Modular Titratable Polypills for Personalized Medicine and Simplification of Complex Medication Regimens
по: Karavasili, Christina, и др.
Опубликовано: (2024)

Polypill eligibility and equivalent intake in a Swiss population-based study
по: Julien Castioni, и др.
Опубликовано: (2021-03-01)

Correction: An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.
по: PLOS ONE Staff
Опубликовано: (2019-01-01)

Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
по: José M. Mostaza, и др.
Опубликовано: (2022-12-01)